Diagnostic performance of non-invasive, stool-based molecular assays in patients with paucibacillary tuberculosis

• Published in: Scientific reports Vol. 10; no. 1; p. 7102
• Main Authors: Gaur, Mohita, Singh, Anoop, Sharma, Vishal, Tandon, Gayatri, Bothra, Ankur, Vasudeva, Aarushi, Kedia, Shreeya, Khanna, Ashwani, Khanna, Vishal, Lohiya, Sheelu, Varma-Basil, Mandira, Chaudhry, Anil, Misra, Richa, Singh, Yogendra
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 28.04.2020; Nature Publishing Group
• Subjects: 38/77; 45/77; 692/699/255/1318; 692/699/255/1856; Adolescent; Adult; Child; Child, Preschool; Deoxyribonucleic acid; DNA; Feces - microbiology; Female; Humanities and Social Sciences; Humans; India; Infant; Infant, Newborn; Lymph nodes; Male; Middle Aged; multidisciplinary; Mycobacterium tuberculosis; Patients; Pleural effusion; Polymerase chain reaction; Science; Science (multidisciplinary); Tuberculosis; Tuberculosis, Pulmonary - diagnosis; Tuberculosis, Pulmonary - epidemiology; Tuberculosis, Pulmonary - microbiology; India
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-63901-z

Timely diagnosis of paucibacillary tuberculosis (TB) which includes smear-negative pulmonary TB (PTB) and extra-pulmonary TB (EPTB) remains a challenge. This study was performed to assess the diagnostic utility of stool as a specimen of choice for detection of mycobacterial DNA in paucibacillary TB patients in a TB-endemic setting. Stool samples were collected from 246 subjects including 129 TB patients (62 PTB and 67 EPTB) recruited at TB hospital in Delhi, India. Diagnostic efficacy of stool IS6110 PCR ( n  = 228) was measured, using microbiologically/clinically confirmed TB as the reference standard. The clinical sensitivity of stool PCR was 97.22% (95% confidence interval (CI), 85.47-99.93) for detection of Mycobacterium tuberculosis in stool samples of smear-positive PTB patients and 76.92% (CI, 56.35–91.03) in samples from smear-negative PTB patients. Overall sensitivity of PCR for EPTB was 68.66% (CI, 56.16–79.44), with the highest sensitivity for stool samples from patients with lymph node TB (73.5%), followed by abdominal TB (66.7%) and pleural effusion (56.3%). Stool PCR presented a specificity of 95.12%. The receiver operating characteristic curve also indicated the diagnostic utility of stool PCR in TB detection (AUC: 0.882). The performance characteristic of the molecular assay suggests that stool DNA testing has clinical value in detection of TB.